Medication
Taro-Tramadol/acet
DIN 02388197 · Sun Pharma Canada Inc Likely a generic
What it is
- Active ingredients
- Tramadol Hydrochloride — 37.5 mg
- Acetaminophen — 325 mg
- Form and route
- Tablet · Oral
- Schedule
- NARCOTICS (CDSA I)
- Authorised since
- 2012-10-01
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Apo-Tramadol/acet
- Teva-Tramadol/acetaminophen
- Jamp-Acet-Tramadol
- Mar-Tramadol/acet
- Mint-Tramadol/acet
- Auro-Tramadol/acetaminophen
- PRZ-Tramadol/acet
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Ontario Drug Benefit coverage
As of 31 July 2026Off-formulary interchangeable Part III-B
Ontario has designated this product interchangeable with a brand product, but it is not an ODB benefit — Part III-B, Off-Formulary Interchangeable. Ontario does not pay for it under the benefit list.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 37.5mg & 325mg Tab and will substitute one for another at a pharmacy counter in Ontario.
- Apo-Tramadol/acet 02336790Apotex Inc
- Auro-Tramadol/acetaminophen 02439050Auro Pharma Inc
- Jamp-Acet-Tramadol 02388308Jamp Pharma Corporation
- Mar-Tramadol/acet 02388324Marcan Pharmaceuticals Inc
- Mint-Tramadol/acet 02389800Mint Pharmaceuticals Inc
- Teva-Tramadol/acetaminophen 02347180Teva Canada Limited
Ontario lists 4 further products in this group that are not currently marketed in Canada. They are not shown.
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N02AJ13
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N02AJ13, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.